[1]
“DEVELOPMENT AND OPTIMIZATION OF SOLID LIPID NANOPARTICLES OF DASATINIB USING DESIGN OF EXPERIMENTS: IN VITRO DRUGRELEASE AND IN-VIVO PHARMACOKINETIC STUDIES”, INT J OF PHARMA RES BIOMED ANAL, vol. 14, no. 2, pp. 85–105, Apr. 2025, Accessed: May 19, 2026. [Online]. Available: https://ijprba.ijpbcs.com/index.php/ijprba/article/view/27